Model
Edge
Revance Therapeutics Inc.
RVNC
Filing type
8-K
Filing date
Feb 5, 2025
Updated
Feb 6, 2025 ยท 6:59 AM
Copy reference
Filing
8-K
Material Contracts, Completing Asset Acquisition or Sale, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes i
Exhibits
EX-3.1
EX-3.1
EX-3.2
EX-3.2
EX-4.1
EX-4.1
EX-99.1
Material Contracts, Completing Asset Acquisition or Sale, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes i
GRAPHIC
Graphic